PBAC Public Summary Documents - November 2005

Public Summary Documents relating to the November 2005 PBAC Meeting

Page last updated: 07 March 2006

Alefacept, powder for injection, 7.5 mg and 15 mg, Amevive® , November 2005

Atomoxetine hydrochloride, capsules, 10 mg, 18 mg, 25 mg, 40 mg and 60 mg, Strattera®, November 2005

Botulinum toxin type A purified neurotoxin complex, lyophilised powder for I.M. injection, 100 units, Botox®, November 2005

Buprenorphine hydrochloride with naloxone hydrochloride, sublingual tablets, 2 mg (base) - 500 micrograms and 8 mg (base) – 2 mg, Suboxone®, November 2005

Capecitabine tablets, 150mg and 500 mg, Xeloda®, November 2005

Carmustine, implant, 7.7 mg, Gliadel® , November 2005

Cetuximab, solution for IV infusion, 100 mg in 50 mL, Erbitux®, November 2005

Cinacalcet Hydrochloride, tablets, 30 mg, 60 mg, 90 mg, Sensipar®, November 2005

Efalizumab, injection set containing 4 vials powder for injection 125 mg and 4 pre-filled syringes solvent 1.3 mL, Raptiva®, November 2005

Esomeprazole magnesium trihydrate, tablet (enteric coated), equivalent to 20 mg esomeprazole, Nexium®, November 2005

Etanercept, powder for injection, 25 mg, Enbrel®, November 2005

Ezetimibe, tablet, 10 mg, Ezetrol®; ezetimibe with Simvastatin, tablets, 10 mg-40 mg, 10 mg-80 mg, Vytorin® , November 2005

Imiquimod, cream, 12.5 mg per 250 mg single use sachets (5%), Aldara®, November 2005

Latanoprost with Timolol Maleate, eye drops, 50 micrograms-5mg (base) per mL (0.005%-0.5%), 2.5 mL Xalacom®, November 2005

Letrozole, tablet, 2.5 mg, Femara®, November 2005

Lumiracoxib, tablet, 200 mg, Prexige®, November 2005

Macrogol 3350, sachet containing 13.125 g powder, 30, Movicol®; sachet containing 6.563 g powder, 30, Movicol-Half®, November 2005

Methyl aminolevulinate, cream, 160 mg per g, 2g tube, Metvix®, November 2005

Olmesartan medoxomil, tablets, 10 mg, 20 mg, and 40 mg, Olmetec®, November 2005

Peginterferon alfa-2a, injection, single use pre-filled syringe, 135 micrograms and 180 micrograms, Pegasys®, Novembr 2005.

Peginterferon alfa-2b, Single use injection pens containing powder for injection in vials of 50, 80, 100, 120 and 150 micrograms and Ribavirin capsules 200 mg, (all pack sizes), Pegatron®, and peginterferon alfa-2b, single use injection pens containing powder for injection in vials of 50, 80, 100, 120 and 150 micrograms, PEG-Intron Redipen®, November 2005

Pemetrexed disodium, powder for IV infusion (base), 500 mg, Alimta® , November 2005

Risperidone, tablets, 1 mg, 2 mg, 3 mg and 4 mg; oral disintegrating tablets, 1 mg and 2 mg, Quicklet®; oral solution, 1 mg per mL, Risperdal ®, November 2005

Tenofovir disoproxil fumarate with emtricitabine, tablet, 300 mg -200 mg, Truvada®, November 2005

Testosterone undecanoate, injection, 1g in 4 mL Reandron®, November 2005

Trandolapril with Verapamil Hydrochloride, tablet, 2 mg-180 mg, 4 mg-240 mg, Tarka®, November 2005

Travoprost with timolol maleate, eye drops, 40 micrograms-5 mg (base) per mL (0.004%-0.5%), 2.5 mL Extravan®, November 2005

Treprostinil Sodium, injections, 1 mg per mL, 2.5 mg per mL, 5 mg per mL and 10 mg per mL, 20 mL multidose vial, Remodulin®, November 2005

Verteporfin, powder for I.V. infusion, 15 mg, Visudyne®, November 2005